Alzheimer's disease is a burden for patients, care partners, and the healthcare system1
An estimated 5.8 million Americans over the age of 65 are living with dementia due to Alzheimer's disease (AD). That number is projected to reach 13.8 million by 2050.1
Increased prevalence will place greater demands on healthcare providers1
Recent analysis suggests that the US has half of the number of registered geriatricians needed to care for the current population and that only a small percentage of nurse practitioners, social workers, and other professionals are skilled in working with older adults.
According to one estimate, the US is projected to need three times the current number of geriatricians to meet the needs of dementia patients in 2050
An Alzheimer's Association survey revealed that many primary care physicians (PCPs) feel under-equipped to manage the increasing AD population1
Advanced diagnostic techniques may have a role to play
Biomarker testing is often used in Alzheimer’s clinical trials. While biomarker testing is not currently recommended for routine clinical practice, it may be a useful tool when deemed appropriate by the clinician.2-5
Access to specialists and diagnostic centers is important for appropriate care.
Locating AD specialists or diagnostic centers with amyloid beta biomarker testing may help support an early AD diagnosis
Read more here : https://www.doximity.com/doc_news/v2/sponsored_entries/aHR0cHM6Ly9jYW1wYWlnbnMuZG94aW1pdHkuY29tL2FwaS92Mi9kZWxpdmVyaWVzLzFlOTI1NDAzLTk5NDctNDhhYS1hZWQyLTcyMjM3MWViOTU1Mj9jaGFubmVsPWVtYWlsX2RpZ2VzdA%3D%3D?_eda_link_uuid=14bcf566-a4de-447b-879f-7afeb25183ec&_r=1&_ref=digest&channel=email_digest&clicked=true&position=3&source=email_doc_news%3A%3Alocal_news_digest&utm_campaign=doc_news%3A%3Alocal_news_digest&utm_source=doximity-eda&utm_medium=email